Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impairment

Clinical trial NCT05086107 · COMPLETED

Trial details

NCT number: NCT05086107
Sponsor: BioVersys AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Impairment

Start date: 2021-10-08
Primary completion: 2022-05-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.